Drug major Cipla has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Ajay Kumar Pal, the chief executive officer of Quality Chemical Industries Limited (QCILl), tells Deogratius Wamala about a ...

Cipla, India's third-biggest drugmaker by sales, reported a fourth-quarter profit that beat estimates on Tuesday, helped by ...

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded the inspection with ...

Cipla, India's No. 3 drugmaker by sales, reported a fourth-quarter profit that beat estimates on Tuesday, helped by strong ...

Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment. Cipla has launched an innovative combination of 3 HIV/AIDS ...

NEW DELHI: Indian Pharmaceutical company Cipla has offered to manufacture an ... particular drug than the individual effect of both the drugs combined. India To Procure 1 Million Doses Of Tamiflu ...

Cipla subsidiary InvaGen issued a voluntary ... is NB301030 with an expiration date of March 2025. The medicine was distributed nationwide in the U.S. In a notice posted on the FDA website ...

"Going forward all our growth engines will be fueled by our digital transformation initiatives," Cipla Managing Director and Global ... innovative drug-device combinations and even bio-drugs that are ...

Cipla Ltd is preparing to launch drugs for diabetes and obesity in India, other emerging markets, and the US, as it sees a huge opportunity for these formulations, a top official of the ...

Cipla, which also makes anti-allergic drug Cetirizine, said revenue from its drugs business in India rose 3.5%, while revenue from its North American market surged 39%. Cipla's profit growth had ...